MC2002A1 - Polypeptides interleukines-1alpha humaines recombines - Google Patents

Polypeptides interleukines-1alpha humaines recombines

Info

Publication number
MC2002A1
MC2002A1 MC892025A MC2025A MC2002A1 MC 2002 A1 MC2002 A1 MC 2002A1 MC 892025 A MC892025 A MC 892025A MC 2025 A MC2025 A MC 2025A MC 2002 A1 MC2002 A1 MC 2002A1
Authority
MC
Monaco
Prior art keywords
thr
asn
asp
leu
phe
Prior art date
Application number
MC892025A
Other languages
English (en)
French (fr)
Inventor
T Lomedico Peter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2002A1 publication Critical patent/MC2002A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MC892025A 1988-01-15 1989-01-12 Polypeptides interleukines-1alpha humaines recombines MC2002A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14445788A 1988-01-15 1988-01-15

Publications (1)

Publication Number Publication Date
MC2002A1 true MC2002A1 (fr) 1990-01-26

Family

ID=22508674

Family Applications (1)

Application Number Title Priority Date Filing Date
MC892025A MC2002A1 (fr) 1988-01-15 1989-01-12 Polypeptides interleukines-1alpha humaines recombines

Country Status (19)

Country Link
EP (1) EP0324447B1 (da)
JP (1) JP2567079B2 (da)
AR (1) AR245958A1 (da)
AT (1) ATE142696T1 (da)
AU (1) AU616461B2 (da)
DE (1) DE58909723D1 (da)
DK (1) DK16489A (da)
ES (1) ES2091752T3 (da)
FI (1) FI890175L (da)
GR (1) GR3021887T3 (da)
HU (1) HU208996B (da)
IE (1) IE890087L (da)
IL (1) IL88934A (da)
MC (1) MC2002A1 (da)
NO (1) NO890174L (da)
NZ (1) NZ227594A (da)
PT (1) PT89438B (da)
YU (1) YU6889A (da)
ZA (1) ZA89202B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
DE3818660A1 (de) * 1987-06-05 1988-12-15 Colgate Palmolive Co Freifliessendes, pulvriges geschirrwaschmittel und verfahren zur herstellung desselben
US5120534A (en) * 1988-07-29 1992-06-09 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and medicament for treating thrombocytopenia
US7176179B1 (en) 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US6191269B1 (en) * 1997-05-30 2001-02-20 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US20030154504A1 (en) 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
DE10252634A1 (de) * 2002-11-11 2004-05-27 Umwelttechnik Georg Fritzmeier Gmbh & Co. Reinigungsmittel und Verfahren zu seiner Herstellung
US20120219511A1 (en) * 2009-09-29 2012-08-30 Igor Arturovich Petropavlov Oral care compositions containing human recombinant interleukin-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
DE3515217A1 (de) * 1985-04-26 1986-10-30 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zur messung schwacher magnetfelder
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha

Also Published As

Publication number Publication date
AU616461B2 (en) 1991-10-31
NO890174L (no) 1989-07-17
JPH025892A (ja) 1990-01-10
IL88934A0 (en) 1989-08-15
EP0324447B1 (de) 1996-09-11
AR245958A1 (es) 1994-03-30
FI890175A7 (fi) 1989-07-16
AU2850989A (en) 1989-07-20
GR3021887T3 (en) 1997-03-31
YU6889A (en) 1990-08-31
HUT50505A (en) 1990-02-28
JP2567079B2 (ja) 1996-12-25
IL88934A (en) 1994-05-30
DE58909723D1 (de) 1996-10-17
EP0324447A2 (de) 1989-07-19
ES2091752T3 (es) 1996-11-16
FI890175L (fi) 1989-07-16
EP0324447A3 (de) 1990-01-31
PT89438B (pt) 1993-09-30
HU208996B (en) 1994-09-28
DK16489A (da) 1989-07-16
FI890175A0 (fi) 1989-01-13
IE890087L (en) 1989-07-15
ZA89202B (en) 1989-09-27
PT89438A (pt) 1990-02-08
NO890174D0 (no) 1989-01-13
DK16489D0 (da) 1989-01-13
NZ227594A (en) 1991-09-25
ATE142696T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
JP3754072B2 (ja) 摂食抑制ペプチド
EP0293357B1 (fr) Expression de la proapolipoprotéine A-I humaine
EP0335243B1 (en) Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
CH675423A5 (da)
DE69434890T2 (de) Klonierung und rekombinante herstellung von vespidengift-hyaluronidase und darauf beruhende immunologische therapien
CN113265007B (zh) 一种治疗代谢疾病的融合蛋白及其制备方法和应用
TW200829600A (en) Protease resistant insulin analogues
PL188387B1 (pl) Białko o aktywności hamującej proteazę serynową, kompozycja farmaceutyczna, wyodrębniona sekwencja,samopowtarzający się wektor, zastosowanie białka o aktywności proteazy serynowej, sposób hamowania aktywności proteazy serynowej ex vivo i sposób wytwarzania białka
CA2229450A1 (en) Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions
MC2002A1 (fr) Polypeptides interleukines-1alpha humaines recombines
EP0273800B1 (fr) Variants de l'hirudine, leur utilisation et leur préparation
JPH06501158A (ja) アプロチニン類似体
EP1009767A1 (fr) Defensine humaine def-x, gene et cdna, composition les contenant et applications au diagnostic et a la therapie
CN101218249A (zh) 胸腺素β4衍生物及其应用
WO1998008512A1 (en) Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
EP0586667A1 (en) Refolding and purification of insulin-like growth factor i
EP0972042A1 (fr) Polypeptide exprimee dans la couche cornee de l'epiderme et son utilisation
JP3451572B2 (ja) 改変したダニ主要アレルゲン及びその製造方法
KR19980064258A (ko) 항비만 단백질
FR2657881A1 (fr) Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides.
CA2125008A1 (en) Peptide and dnas encoding it
EP0686194A1 (fr) Facteurs de croissance de la famille de l'harp, procede d'obtention et applications
WO2001090356A1 (fr) Promoteur de pgc-1 humain
WO1995013302A1 (en) Cathepsin-l-specific inhibitor polypeptide
JPH0380096A (ja) モチリン様ポリペプチドの製法並びにそのための組換えｄｎａ及び発現用プラスミド

Legal Events

Date Code Title Description
YP Annual fee paid